Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections

Infection Control and Hospital Epidemiology

Volumn 33, Issue 11, 2012, Pages 1094-1100

  Rupp, Mark E ^a,b   Jennifer Cavalieri, R ^a   Lyden, Elizabeth ^c   Kucera, Jennifer ^a   Martin, MaryAnn ^b   Fitzgerald, Teresa ^b   Tyner, Kate ^b   Anderson, James R ^c   VanSchooneveld, Trevor C ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE;

AQUEOUS SOLUTION; ARTICLE; BACTERIAL COLONIZATION; BATH; BLOODSTREAM INFECTION; CATHETER ASSOCIATED URINARY TRACT INFECTION; CATHETER INFECTION; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DISEASE ASSOCIATION; DISINFECTION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN INTENSIVE CARE; NURSING STAFF; PATIENT COMPLIANCE; PATIENT MONITORING; QUASI EXPERIMENTAL STUDY; RISK ASSESSMENT; RISK REDUCTION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

ACADEMIC MEDICAL CENTERS; ANTI-INFECTIVE AGENTS; BATHS; CHLORHEXIDINE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HOSPITALIZATION; HUMANS; POISSON DISTRIBUTION;

EID: 84867484375     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/668024     Document Type: Article

References (23)

1. Klevins RM, Edwards JR, Richards CL, et al. Estimating healthcare-associated infections in U.S. hospitals, 2002. Public Health Rep 2007;122(2):160-166.
2. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011;32(2): 101-114.
3. Scott RD II. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. Division of Healthcare Quality Promotion, Centers for Diseases Control and Prevention. http://www.cdc.gov/hai/pdfs/hai/scott _costpaper.pdf. Published March 2009. Accessed September 23, 2011.
4. Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008;46(2):274-281.
5. Denton GW. Chlorhexidine. In: Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001:321-336.
6. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167(19):2073-2079.
7. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillinresistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009; 37(6):1858-1865.
8. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009;30(10):959-963.
9. Vernon MO, Hayden MK, Trick WE, Hayes RA, Bloom DW, Weinstein RA. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006;166(3):306-312.
10. Evans HL, Dellit TH, Chan J, Nathens AB, Maier RV, Cuschieri J. Effect of chlorhexidine whole-body bathing on hospitalacquired infections among trauma patients. Arch Surg 2010; 145(3):240-246.
11. Munoz-Price LS, Hota B, Stemer A, Weinstein RA. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30(11):1031-1035.
12. Kassakian SZ, Mermel LA, Jefferson JA, Parenteau SL, Machan JT. Impact of chlorhexidine bathing on hospital-acquired infection among general medical patients. Infect Control Hosp Epidemiol 2011;32(3):238-243.
13. Centers for Disease Control and Prevention, National Healthcare Safety Network. NHSN patient safety component manual. http://www.cdc.gov/nhsn/TOC_PSCManual.html. Accessed December 30, 2011.
14. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28(2):140-145.
15. Wenzel RP, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010;14(suppl 4):S3-S5.
16. Hibiclens [material safety data sheet]. Wilmington, DE: ICI Americas, 1987.
17. Jury LA, Guerrero DM, Burant CJ, Cadnum JL, Donskey CJ. Effectiveness of routine patient bathing to decrease the burden of spores on the skin of patients with Clostridium difficile infection. Infect Control Hosp Epidemiol 2011;32(2):181-184.
18. Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M. Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006. Infect Control Hosp Epidemiol 2010;31(9): 939-947.
19. Dixon JM, Carver RL. Daily chlorhexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections. Am J Infect Control 2010;38(10):817-821.
20. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52(9):1087-1099.
21. Batra R, Cooper BS, Shiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50(2):210-217.
22. Lee AS, Macedo-Vinas M, François P, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011;52(12):1422-1430.
23. Liu Q, Liu M, Wu Q, Li C, Shou T, Ni Y. Sensitivities to biocides and distribution of biocide resistance genes in quaternary ammonium compound tolerant Staphylococcus aureus isolated in a teaching hospital. Scan J Infect Dis 2009;41(6-7):403-409.